What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
His primary scientific interests are in Immunology, Cytokine, Inflammation, Inflammatory bowel disease and Colitis.
As part of one scientific family, Markus F. Neurath deals mainly with the area of Immunology, narrowing it down to issues related to the Lamina propria, and often Cytokine secretion and Apoptosis.
Markus F. Neurath has included themes like Molecular biology and Interleukin 12 in his Cytokine study.
His Inflammation research focuses on Arthritis and how it connects with Rheumatoid arthritis.
The concepts of his Inflammatory bowel disease study are interwoven with issues in Crohn's disease, Immunotherapy, Endocrinology and Ulcerative colitis.
His Colitis research is multidisciplinary, relying on both Oxazolone, Pancolitis, T cell, Interferon and Interleukin 10.
His most cited work include:
- RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. (1596 citations)
- Antibodies to interleukin 12 abrogate established experimental colitis in mice. (1225 citations)
- Cytokines in inflammatory bowel disease (1134 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Immunology, Internal medicine, Inflammatory bowel disease, Gastroenterology and Pathology.
His work in Immune system, Inflammation, Cytokine, Colitis and Pathogenesis is related to Immunology.
Markus F. Neurath combines subjects such as Cancer research and Colorectal cancer with his study of Colitis.
His work on Ulcerative colitis, Crohn's disease, Colonoscopy and Endoscopy as part of his general Internal medicine study is frequently connected to In patient, thereby bridging the divide between different branches of science.
In his research on the topic of Gastroenterology, Radiology is strongly related with Chromoendoscopy.
His Pathology study incorporates themes from Confocal, Endomicroscopy, Molecular imaging, In vivo and Confocal laser endomicroscopy.
He most often published in these fields:
- Immunology (29.30%)
- Internal medicine (24.75%)
- Inflammatory bowel disease (18.29%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (24.75%)
- Inflammatory bowel disease (18.29%)
- Immunology (29.30%)
In recent papers he was focusing on the following fields of study:
Markus F. Neurath mainly focuses on Internal medicine, Inflammatory bowel disease, Immunology, Ulcerative colitis and Gastroenterology.
His Disease, Adverse effect and Randomized controlled trial study, which is part of a larger body of work in Internal medicine, is frequently linked to In patient, bridging the gap between disciplines.
His studies deal with areas such as Infliximab and Bioinformatics as well as Inflammatory bowel disease.
His Immunology and Immune system, Inflammation, Antibody, Pathogenesis and Interleukin 23 investigations all form part of his Immunology research activities.
His Immune system research integrates issues from Tumor necrosis factor alpha, Cell and Cytokine.
The study incorporates disciplines such as Crohn's disease, Clinical trial, Colitis and Flow cytometry in addition to Ulcerative colitis.
Between 2017 and 2021, his most popular works were:
- Environmental triggers in IBD: a review of progress and evidence. (201 citations)
- COVID-19: risk for cytokine targeting in chronic inflammatory diseases? (167 citations)
- Targeting immune cell circuits and trafficking in inflammatory bowel disease. (107 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
